Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children?

MLA

Tezcan, Mustafa Esad, et al. “Do Specific Myelin Autoantibodies and Increased Cerebral Dopamine Neurotrophic Factor in the Context of Inflammation Predict the Diagnosis of Attention Deficit Hyperactivity Disorder in Medication-Free Children?” Brain, Behavior, and Immunity, vol. 124, Feb. 2025, pp. 125–36. EBSCOhost, https://doi.org/10.1016/j.bbi.2024.11.026.

APA

Tezcan, M. E., Ekici, F., Ugur, C., Can, Ü., Karatoprak, S., Sağlıyan, G. A., Uçak, E. F., Güleç, A., Erbasan, V., Sen, B., Simsek, F., & Atas, A. E. (2025). Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children? Brain, Behavior, and Immunity, 124, 125–136. https://doi.org/10.1016/j.bbi.2024.11.026

Chicago

Tezcan, Mustafa Esad, Fatih Ekici, Cüneyt Ugur, Ümmügülsüm Can, Serdar Karatoprak, Gökçeçiçek Arıcı Sağlıyan, Ekrem Furkan Uçak, et al. 2025. “Do Specific Myelin Autoantibodies and Increased Cerebral Dopamine Neurotrophic Factor in the Context of Inflammation Predict the Diagnosis of Attention Deficit Hyperactivity Disorder in Medication-Free Children?” Brain, Behavior, and Immunity 124 (February): 125–36. doi:10.1016/j.bbi.2024.11.026.